Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...
News Medical on MSN14d
New blood test achieves 98% accuracy in diagnosing ALSA highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...
A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...
Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...
3d
About Rozebalamin (generic name: mecobalamin, development code: E0302) ...
(Lawrenceburg, IN) – The 8th annual Cruisin’ to a Cure for ALS (Amyotrophic Lateral Sclerosis) car show in Lawrenceburg set ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback